𝔖 Bobbio Scriptorium
✦   LIBER   ✦

B cell hyperactivity and its relation to distinct clinical features and the degree of disease activity in patients with systemic lupus erythematosus

✍ Scribed by Tsuyoshi Sakane; Noboru Suzuki; Shinsuke Takada; Yuji Ueda; Yohko Murakawa; Tomiko Tsuchida; Yasutaka Yamauchi; Tadamitsu Kishimoto


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
809 KB
Volume
31
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Activation of the interferon-α pathway i
✍ Kyriakos A. Kirou; Christina Lee; Sandhya George; Kyriakos Louca; Margaret G. E. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract ## Objective Gene‐expression studies have demonstrated increased expression of interferon (IFN)–inducible genes (IFIGs) in peripheral blood mononuclear cells (PBMCs) of many patients with systemic lupus erythematosus (SLE), with a predominant effect of type I IFN. This study examined t

Autoantibodies to the translational supp
✍ Esther Jimenez-Boj; Nancy Kedersha; Makiyeh Tohidast-Akrad; Franz M. Karlhofer; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB

## Abstract ## Objective T cell intracytoplasmic antigen 1 (TIA‐1) and TIA‐1–related protein (TIAR) are involved in posttranscriptional regulation of the expression of tumor necrosis factor α (TNFα) and other proteins. Given the pivotal role of TNFα in chronic inflammatory diseases, this study was

Assessment of disease activity and impen
✍ Jill P. Buyon; John Tamerius; H. Michael Belmont; Steven B. Abramson 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 849 KB

## Abstract __Objective.__ To determine whether increased levels of the complement split products generated in the activation of the alternative or classical pathway accompany more severe disease activity in patients with systemic lupus erythematosus (SLE) and whether these measurements are useful